Spinal Tech

NuVasive Reports $124.5M in Q1 Total Revenue, 14.1% Increase

NuVasive, a medical device company focused on surgical products and procedures for the spine, has posted total revenue of $124.5 million for the first quarter of 2011, representing a 14.1 percent increase over the same period last year, according to a company news release.

Jaimie Oh

Wednesday, May 18th, 2011

The device company, however, experienced a slight decline in revenue from the fourth quarter of 2010, which sat at approximately $129.3 million. According to the news release, the sequential decrease was driven in part by approximately $4 million in seasonal capital purchases and back royalties related to a settlement in 4Q 2010.

Read the company news release about NuVasive’s financial results.

Next Up in Spinal Tech

Spark Spine snags patent allowance for fusion implants

Spark Spine earned a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary spinal implant architectures,…

By: Carly Behm
Friday, January 23rd, 2026
Curiteva surpasses 10,000 spine levels treated

Curiteva’s Inspire spine implants have been used in more than 10,000 levels, the medtech company said Jan. 21. The interbody…

By: Carly Behm
Thursday, January 22nd, 2026
Omnia Medical launches sacroiliac joint system

Medtech company Omnia Medical has commercially launched its PsiF DNA Sacroiliac Joint Stabilization System. The system is intended to be…

By: Cameron Cortigiano
Wednesday, January 21st, 2026

Comments are closed.

Practical guidance for predictive flow: How University Health is improving ED + inpatient throughput

Next Up in Spinal Tech

Spark Spine snags patent allowance for fusion implants

Curiteva surpasses 10,000 spine levels treated

Omnia Medical launches sacroiliac joint system

Join the spine leaders & surgeons who start their day with Becker's